Active Surveillance for Cancer of the Prostate (ASCaP)

About

Brief Summary

Active Surveillance (A.S.) of prostate cancer (CaP) is the systematic monitoring of men with low-risk, localized lesions, with curative treatment of those whose tumors show substantial progression. A.S. is different from Watchful Waiting (W.W.), which is the palliative treatment of men with progressive prostate cancer.

Study Type

Observational

Phase

N/A

Eligibility

Gender

Male

Healthy Volunteers

No

Minimum Age

30 Years

Maximum Age

85 Years

Inclusion Criteria:

Histologically confirmed adenocarcinoma of the prostate.
Clinically localized prostate cancer: T1-2, NX or N0, MX or M0.
No previous treatment for prostate cancer (including hormonal therapy, radiation therapy, surgery, or chemotherapy).
Patient has elected Active Surveillance as preferred management plan for prostate cancer.
Patient consent has been obtained according to local Institutional Review Board .
Patient is accessible and compliant for follow-up.